AngioDynamics reported $77.97M in Current Liabilities for its fiscal quarter ending in February of 2025.





Current Liabilities Change Date
AngioDynamics USD 77.97M 10.62M Feb/2025
AtriCure USD 77.84M 9M Sep/2025
Boston Scientific USD 5.33B 138M Sep/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
ICU Medical USD 492.9M 10.12M Sep/2025
Inogen USD 64.94M 2.12M Sep/2025
J&J USD 54.13B 3.26B Dec/2025
Medtronic USD 11.53B 1.35B Jun/2025
Merit Medical Systems USD 230.48M 4.9M Sep/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 159.85M 11.47M Sep/2025
Smiths GBP 959M 90M Dec/2025
Surmodics USD 20.54M 347K Sep/2024
Tandem Diabetes Care USD 252.54M 852K Sep/2025
Teleflex USD 773.03M 56.88M Sep/2025
Terumo JPY 296.3B 24.4B Sep/2025
Trinity Biotech USD 34.49M 2.97M Sep/2025